These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 21794813)

  • 1. [Reactivation of hepatitis B in a patient with spondyloarthritis after the suspension of methotrexate and efficacy of treatment with antivirals in association to adalimumab].
    Cobeta García JC; Medrano M
    Reumatol Clin; 2011; 7(3):200-2. PubMed ID: 21794813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adefovir combined with hepatitis C virus treatment may prevent hepatitis B reactivation after hepatitis C virus eradication in hepatitis B and C virus carriers.
    Renou C; Cadranel JF; Pariente A; Pénaranda G; Bourlière M; Halfon P; Igual JP; Harafa A; Muller P; Bertrand JJ; Laugier R
    Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1235-7. PubMed ID: 18989147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adefovir-lamivudine combination therapy and hepatitis B viral kinetics.
    Mutimer D
    J Hepatol; 2005 Aug; 43(2):200-2. PubMed ID: 15975684
    [No Abstract]   [Full Text] [Related]  

  • 5. Adefovir added to lamivudine for hepatitis B recurrent infection in refractory B-cell chronic lymphocytic leukemia on prolonged therapy with Campath-1H.
    Cortelezzi A; Viganò M; Zilioli VR; Fantini NN; Pasquini MC; Deliliers GL; Colombo M; Lampertico P
    J Clin Virol; 2006 Apr; 35(4):467-9. PubMed ID: 16316778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment with tenofovir in a child C cirrhotic patient with lamivudine-resistant hepatitis B virus awaiting liver transplantation. Post-transplant results.
    Taltavull TC; Chahri N; Verdura B; Gornals J; Lopez C; Casanova A; Cañas C; Figueras J; Casais LA
    Transpl Int; 2005 Jul; 18(7):879-83. PubMed ID: 15948869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lamivudine and adefovir dipivoxil combination treatment for liver cirrhosis patients with CHB].
    Yang DH; Xie SF; Wang YM; Zhao NF; Li MW
    Zhonghua Gan Zang Bing Za Zhi; 2008 Jun; 16(6):473-4. PubMed ID: 18579006
    [No Abstract]   [Full Text] [Related]  

  • 8. Successful treatment of fibrosing cholestatic hepatitis using adefovir dipivoxil in a patient with cirrhosis and renal insufficiency.
    Tillmann HL; Bock CT; Bleck JS; Rosenau J; Böker KH; Barg-Hock H; Becker T; Trautwein C; Klempnauer J; Flemming P; Manns MP
    Liver Transpl; 2003 Feb; 9(2):191-6. PubMed ID: 12548514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: final long-term results.
    Schiff E; Lai CL; Hadziyannis S; Neuhaus P; Terrault N; Colombo M; Tillmann H; Samuel D; Zeuzem S; Villeneuve JP; Arterburn S; Borroto-Esoda K; Brosgart C; Chuck S;
    Liver Transpl; 2007 Mar; 13(3):349-60. PubMed ID: 17326221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy.
    Ijaz S; Arnold C; Dervisevic S; Mechurova J; Tatman N; Tedder RS; Naoumov NV
    J Med Virol; 2008 Jul; 80(7):1160-70. PubMed ID: 18461609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.
    Manolakopoulos S; Bethanis S; Koutsounas S; Goulis J; Vlachogiannakos J; Christias E; Saveriadis A; Pavlidis C; Triantos C; Christidou A; Papatheodoridis G; Karamanolis D; Tzourmakliotis D
    Aliment Pharmacol Ther; 2008 Feb; 27(3):266-73. PubMed ID: 17988233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Outcome of chronic hepatitis B and C in patients with inflammatory bowel disease treated with immunosuppressive drugs and anti-TNF agents].
    González-Artacho C; Rodríguez Sicilia MJ; Alegría-Motte C; Gómez García M
    Gastroenterol Hepatol; 2014 Jan; 37(1):23-4. PubMed ID: 24094622
    [No Abstract]   [Full Text] [Related]  

  • 13. Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy.
    Liang Y; Jiang J; Su M; Liu Z; Guo W; Huang X; Xie R; Ge S; Hu J; Jiang Z; Zhu M; Wong VW; Chan HL
    Aliment Pharmacol Ther; 2011 Aug; 34(3):344-52. PubMed ID: 21671967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute hepatitis B: is antiviral therapy indicated? Two case reports].
    Girke J; Wedemeyer H; Wiegand J; Manns MP; Tillmann HL
    Dtsch Med Wochenschr; 2008 May; 133(22):1178-82. PubMed ID: 18491273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B virus kinetics and mathematical modeling.
    Perelson AS; Ribeiro RM
    Semin Liver Dis; 2004; 24 Suppl 1():11-6. PubMed ID: 15192796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on the efficacy and safety of adefovir dipivoxil treatment in post-liver transplant patients with hepatitis B virus infection and lamivudine-resistant hepatitis B virus.
    Bárcena R; Del Campo S; Moraleda G; Casanovas T; Prieto M; Buti M; Moreno JM; Cuervas V; Fraga E; De la Mata M; Otero A; Delgado M; Loinaz C; Barrios C; Dieguez ML; Mas A; Sousa JM; Herrero JI; Muñoz R; Avilés JF; Gonzalez A; Rueda M
    Transplant Proc; 2005 Nov; 37(9):3960-2. PubMed ID: 16386596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
    Long M; Jia W; Li S; Jin L; Wu J; Rao N; Feng H; Chen K; Deng H; Liu F; Su F; Song E
    Breast Cancer Res Treat; 2011 Jun; 127(3):705-12. PubMed ID: 21445574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B virus genotypes and response to antiviral therapy.
    Enomoto M; Tamori A; Nishiguchi S
    Clin Lab; 2006; 52(1-2):43-7. PubMed ID: 16506363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lamivudine monoprophylaxis and adefovir salvage for liver transplantation in chronic hepatitis B: a seven-year follow-up study.
    Limquiaco JL; Wong J; Wong VW; Wong GL; Tse CH; Chan HY; Kwan KY; Lai PB; Chan HL
    J Med Virol; 2009 Feb; 81(2):224-9. PubMed ID: 19107976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of chronic hepatitis B with primary adefovir resistance].
    Yamazhan T; Sertöz R; Pullukçu H; Taşbakan M; Ulusoy S; Erensoy S
    Mikrobiyol Bul; 2007 Apr; 41(2):297-301. PubMed ID: 17682718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.